ARS Pharmaceuticals, Inc. ( SPRY) - Key Metrics
SPRY Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.28 | -$0.42 | -$0.44 | -$0.44 |
| 2025Q3 | $0.33 | -$0.52 | -$0.48 | -$0.48 |
| 2025Q2 | $0.16 | -$0.46 | -$0.40 | -$0.40 |
| 2025Q1 | $0.08 | -$0.35 | -$0.42 | -$0.42 |
SPRY Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -6.95 |
| 2025Q3 | ? | -4.85 |
| 2025Q2 | ? | -9.56 |
| 2025Q1 | ? | -9.09 |
SPRY
Price: $9.81
52 week price:
Earnings Per Share: -2.00 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 850.0 million